A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus
Open Access
- 12 October 2001
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (10) , 2350-2357
- https://doi.org/10.1002/1529-0131(200110)44:10<2350::aid-art398>3.0.co;2-a
Abstract
Objective To determine the degree to which changes in C3 and C4 precede or coincide with changes in systemic lupus erythematosus (SLE) activity, as measured by 5 global activity indices, the physician's global assessment (PGA), modified SLE Disease Activity Index (M‐SLEDAI), modified Lupus Activity Index (M‐LAI), Systemic Lupus Activity Measure (SLAM), and the modified British Isles Lupus Assessment Group (M‐BILAG), and to evaluate the association between changes in C3 and C4 levels and SLE activity in individual organ systems. Methods Fifty‐three lupus patients were observed monthly for 1 year in a longitudinal study. Lupus disease activity and complement levels were measured at each visit. Lupus flare was defined as a 1.0 (or greater) increase in the PGA, a 3‐point increase in the M‐SLEDAI, a 0.1 increase in the M‐LAI, a 3‐point increase in the SLAM, or a 4‐point increase in the M‐BILAG within a 1‐month period. Flare rates were calculated for subgroups defined by previous (1 month before) or concurrent changes in complement levels. Logistic regression models were used to determine the significance of the association between recent changes in complement levels and flare, controlling for prednisone dosage. Similar models were used to assess the association between changes in C3 or C4 levels and increased SLE activity in specific organ systems. Results Lupus flares occurred at 12% of visits based on the PGA, 19% based on the M‐SLEDAI, 25% based on the M‐LAI, 13% based on the SLAM, and 12% based on the M‐BILAG. Recent changes in C3 and C4 levels were not associated with flares based on 3 of the 5 activity indices. Flares defined by the M‐LAI were more frequent when there was a concurrent decrease in C3 (odds ratio [OR] 1.9, 95% confidence interval [95% CI] 1.1–3.1) or C4 (OR 2.1, 95% CI 1.3–3.6). Higher flare rates, as defined by the SLAM, were associated with previous increases in C3 (OR 1.6, 95% CI 1.0–2.6) and C4 (OR 2.2, 95% CI 1.2–3.9). When individual organ systems were analyzed, decreases in C3 and C4 were associated with a concurrent increase in renal disease activity (OR 2.2, 95% CI 1.4–3.5 and OR 1.9, 95% CI 1.1–3.4, respectively). Decreases in C3 were also associated with concurrent decreases in the hematocrit (OR 4.6, 95% CI 1.7–12.3), platelet (OR 2.5, 95% CI 1.5–4.1), and white blood cell (OR 2.2, 95% CI 1.3–3.6) counts. Previous increases in C3 levels were associated with a decrease in platelets (OR 1.7, 95% CI 1.1–2.7). A decrease in C4 was associated with a concurrent decrease in the hematocrit level (OR 3.2, 95% CI 1.3–7.5) and platelet count (OR 1.6, 95% CI 1.0–2.5). Conclusion Decreases in complement levels were not consistently associated with SLE flares, as defined by global measures of disease activity. However, decreasing complement was associated with a concurrent increase in renal and hematologic SLE activity.Keywords
This publication has 34 references indexed in Scilit:
- Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests failArthritis & Rheumatism, 1996
- The Value of Complement Activation Products in the Assessment of Systemic Lupus Erythematosus FlaresClinical Immunology and Immunopathology, 1995
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Measurement of increases in anti‐double‐stranded dna antibody levels as a predictor of disease exacerbation in systemic lupus erythematosusArthritis & Rheumatism, 1990
- Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1986
- Ro (SS‐A) antibody and antigen in a patient with congenital complete heart blockArthritis & Rheumatism, 1985
- Sunlight-Induced Pathogenesis in Systemic Lupus ErythematosusJournal of Investigative Dermatology, 1985
- Radioimmunoassay of the Attack Complex of Complement in Serum from Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- Complement in thrombotic thrombocytopenic purpuraAmerican Journal of Hematology, 1983
- Glomerular Complement Components in Human GlomerulonephritisJournal of Clinical Investigation, 1974